TrialsgrambetaRCTs are beautiful

AASK

2002

African American Study of Kidney Disease and Hypertension

In 1,094 Black patients with hypertensive nephrosclerosis, ramipril slowed kidney-disease progression compared with amlodipine or metoprolol.

Result

Primary endpoint: Composite of GFR decline, ESRD or death

Ramipril vs amlodipine 38% risk reduction in clinical composite (95% CI 14–56%, p=0.004).

Original publication
Subtopic
RAAS blockade
Design
3×2 factorial RCT
Relevance
Important: one of several pillars.
Source
Wright JT, et al. JAMA. 2002;288(19):2421-2431.doi 10.1001/jama.288.19.2421

Discussion & critique

The only major CKD trial conducted entirely in a Black population; informed the later blood-pressure-target debate.

Discussed in podcasts